Herceptin 400 mg Injection
$950.00
Herceptin 400 mg Injection
| Type | CANCER |
| Brand Name | Roche |
| Certification | FDA |
| Warranty | 2 YEARS |
| Male End Type | UNISEX |
| Medicine Type | Allopathic |
| Form | Liquid |
| Strength | 400 mg |
| Storage | Cool & Dry Place |
| Pack Type | Vial |
Additional Information
| Min. Order Quantity | 1 Box |
| Port | EUROPE |
| Payment Terms | T/T, Western Union, MoneyGram |
| Delivery Time | 5 DAYS |
| Packaging Details | ICEBOX |
Herceptin 400 mg Injection
Drug class: Antineoplastic agent
Target: HER2/neu
Other names: trastuzumab-anns, trastuzumab-dkst, trastuzumab-dttb, trastuzumab-pkrb, trastuzumab-qyyp
Elimination half-life: 2-12 days
Herceptin (chemical name: trastuzumab) can be used to treat HER2-positive breast cancer that is either early-stage or advanced-stage/metastatic.
Herceptin is currently approved by the U.S. Food and Drug Administration:
to treat metastatic HER2-positive breast cancer to stop the cancer from growing
to treat earlier stages of HER2-positive breast cancer, either as part of a regimen with chemotherapy or alone after a chemotherapy regimen that includes an anthracycline, to reduce the risk of the breast cancer coming back (recurrence)
in combination with Perjeta (chemical name: pertuzumab) and Taxotere (chemical name: docetaxel) before surgery to treat HER2-positive, early-stage (the cancer must be larger than 2 cm or cancer must be in the lymph nodes), inflammatory, or locally advanced-stage breast cancer with a high risk of metastasizing or becoming fatal
in combination with Perjeta and chemotherapy after surgery to treat HER2-positive, early-stage breast cancer with a high risk of recurrence
Reviews
There are no reviews yet.
Related products
ANTI CANCER DRUGS
ANTI CANCER DRUGS
ANTI CANCER DRUGS
ANTI CANCER DRUGS
ANTI CANCER DRUGS
ANTI CANCER DRUGS
ANTI CANCER DRUGS
ANTI CANCER DRUGS
Be the first to review “Herceptin 400 mg Injection”